Inhibiting amyloid-beta cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design.
Cao, Q., Shin, W.S., Chan, H., Vuong, C.K., Dubois, B., Li, B., Murray, K.A., Sawaya, M.R., Feigon, J., Black, D.L., Eisenberg, D.S., Jiang, L.(2018) Nat Chem 10: 1213-1221
- PubMed: 30297750 
- DOI: 10.1038/s41557-018-0147-z
- Primary Citation of Related Structures:  
6BCS - PubMed Abstract: 
Inhibiting the interaction between amyloid-β (Aβ) and a neuronal cell surface receptor, LilrB2, has been suggested as a potential route for treating Alzheimer's disease. Supporting this approach, Alzheimer's-like symptoms are reduced in mouse models following genetic depletion of the LilrB2 homologue ...